Asthma clinical trials at UC Irvine

1 research study open to eligible people

Assessing Rocatinlimab in Moderate-to-severe Asthma
open to eligible people ages 18-75
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.
Orange, California and other locations

Last updated: January 8, 2025